UiPath Inc. experienced a notable increase in its stock value during pre-market trading, propelled by impressive third-quarter financial outcomes and an encouraging sales outlook for the upcoming quarter. This upward trend placed UiPath prominently among a diverse group of companies witnessing significant movements before the official market open.
Detailed Report on Morning Market Activity
On December 4, 2025, UiPath Inc. (NYSE: PATH) recorded a substantial rise in its shares during pre-market trading, climbing approximately 9%. This surge was primarily driven by the company's robust third-quarter performance, which revealed an adjusted earnings per share of 16 cents, surpassing the Street's projection of 15 cents. Furthermore, quarterly revenue reached $411.11 million, comfortably exceeding the consensus estimate of $392.97 million and marking a considerable increase from the $354.65 million reported in the same period last year. The company also provided an optimistic sales guidance for the fourth quarter, with its midpoint exceeding analyst expectations. At the close of pre-market trading, UiPath shares stood at $16.18.
Beyond UiPath, several other companies demonstrated significant shifts in their stock prices:
Notable Gainers Included:
- Polyrizon Ltd. (NASDAQ: PLRZ) saw an extraordinary jump of 158.1% to $18.30. This impressive rise followed the announcement of preclinical data indicating that its proprietary naloxone hydrogel demonstrated superior nasal tissue adherence compared to an existing intranasal naloxone spray.
- Nauticus Robotics, Inc. (NASDAQ: KITT) surged by 34% to $2.09 amidst reports of Commerce Secretary Howard Lutnick's discussions with robotics industry leaders to foster sector growth.
- Picard Medical, Inc. (NYSE: PMI) increased by 22.3% to $2.47.
- Meiwu Technology Company Limited (NASDAQ: WNW) advanced by 20.9% to $1.68 after signing a Memorandum of Understanding with Real BioTech (Qingdao) Ltd.
- Universe Pharmaceuticals INC (NASDAQ: UPC) climbed 19.5% to $4.22.
- Hyster-Yale, Inc. (NYSE: HY) rose by 13.6% to $39.03, extending gains from the previous day.
- KALA BIO, Inc. (NASDAQ: KALA) experienced a 13.5% increase to $1.05 following Securities and Exchange Commission filings that indicated Oxford Finance LLC's acquisition of 1.62 million common shares, representing a 16.5% ownership stake.
- Axogen, Inc. (NASDAQ: AXGN) gained 11% to $31.43 after receiving FDA approval for its Biologics License Application for AVANCE® (acellular nerve allograft–arwx).
- Anbio Biotechnology (NASDAQ: NNNN) jumped 9.7% to $37.88, building on a 25% gain from the prior day.
Significant Losers Included:
- Virax Biolabs Group Ltd (NASDAQ: VRAX) declined 16.2% to $0.58, attributed to definitive agreements to sell 12.5 million ordinary shares at $0.40 per share in a private placement.
- Treasure Global Inc (NASDAQ: TGL) fell 13.3% to $0.26, following an announcement of a 1-for-20 reverse stock split and a Nasdaq delisting notification.
- Net Lease Office Properties (NYSE: NLOP) decreased 14.7% to $25.19.
- Addex Therapeutics Ltd – ADR (NASDAQ: ADXN) dipped 11.4% to $7.84 after reporting a third-quarter loss of $1.50 per share.
- Vicarious Surgical Inc (NYSE: RBOT) shares dropped 11.1% to $2.93, despite a 27% gain on Wednesday, as the company lowered its full-year 2025 cash burn outlook.
- Symbotic Inc (NASDAQ: SYM) fell 10.5% to $65.50 after announcing a 10 million share offering.
- Immuron Ltd – ADR (NASDAQ: IMRN) saw a 9.1% drop to $1.41, extending its Wednesday losses.
- Snowflake Inc (NYSE: SNOW) declined 8.6% to $241.85 after its quarterly results.
- Capricor Therapeutics Inc (NASDAQ: CAPR) dipped 8.4% to $27.45. This came after a massive 371% surge on Wednesday, following positive topline results from its Phase 3 HOPE-3 Trial for Duchenne Muscular Dystrophy.
- Koninklijke Philips NV (NYSE: PHG) fell 6.8% to $26.11.
This dynamic pre-market activity highlights the critical role of financial reports, strategic announcements, and broader market sentiment in shaping investor confidence and immediate stock valuations. For investors, these early movements can signal underlying trends and potential opportunities or risks as the trading day unfolds.